to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In July, the offer for Qiagen was raised from €39 to €43 per share (€11.3 billion in total). On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August 2020, Thermo Fisher Scientific opened its new Lenexa facility aimed at boosting the production and manufacturing of COVID-19 testing supplies. In December the business announced it would acquire Phitonex, Inc. In January 2021, Thermo Fisher Scientific announced it had acquired Belgium-based viral vector manufacturer, Henogen SA, from Groupe Novasep SAS for €725 million in cash and Mesa Biotech, Inc. for up to $550 million. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. PPD generated $4.7 billion in revenue during FY 2020, and this transaction, which values their company at approximately $20.9 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6billion from Nordic Capital. The acquisition completed in January 2023. Thermo Fisher Scientific (formed in 2006 by the merger of Thermo Electron and Fisher Scientific) Thermo Fisher Scientific Fisher Scientific Scientific Materials Co. (Est 1902) Scientific Supplies, Ltd (Acq 1925) Eimer & Amend (Acq 1940) E. Machlett & Sons (Acq 1957) Janssen Chimica Eastman Kodak Company (Organic Chemicals division) Apogent Technologies Inc. (Acq 2004) Athena Diagnostics (Acq 2006) Thermo Electron Kendro Laboratory Products (Acq 2005) Rupprecht and Patashnick Co., Inc. (Acq 2005) NITON LLC (Acq 2005) InnaPhase Corporation (Acq 2004) US Counseling Services, Inc. (Acq 2004) Jouan SA (Acq 2004) Laboratory Management Systems, Inc. (Acq 2003) Phadia (Acq 2011) Life Technologies (Acq 2013) Invitrogen Corporation (Merged 2008) NOVEX Research Genetics, Inc (Acq 1999) Ethrog Biotechnology Molecular Probes Dynal Panvera InforMax BioSource CellzDirect Zymed Caltag Laboratories Applied Biosystems (Merged 2008) Advanced Scientifics (Acq 2015) Alfa Aesar (Acq 2015) Affymetrix (Acq 2016) Genetic MicroSystems (Acq 1999) Neomorphic (Acq 2000) ParAllele Bioscience USB Corporation (Acq 2008) Panomics (Acq 2008) True Materials (Acq 2000) eBioscience (Acq 2012) Compendia Bioscience (Acq 2012) FEI Company (Acq 2016) FEI Company (Merged 1997) Field Electron and Ion Co. (Est